Background
==========

*Salmonellaenterica*is one of the leading causes of food-borne illnesses around the world \[[@B1],[@B2]\]. There are two major serotypes of *Salmonella enterica*, namely *Salmonella enterica*serovar Enteritidis (*S. Enteritidis*) and Typhimurium (*S. Typhimurium*). In recent years, *S. Enteritidis*represents one of the most commonly reported serotypes associated with food poisoning illness in the United States \[[@B3]\]. Two hallmarks of *Salmonella*pathogenesis are the invasion of non-phagocytic cells such as the epithelial cells of the intestinal mucosa, and the survival inside macrophages during systemic infection. The mechanisms of both processes are linked to the functions of two type III secretion systems (T3SS) of *Salmonella*that are encoded and regulated by a cluster of genes at the *Salmonella*Pathogenicity Island 1 and 2 (SPI-1 and SPI-2), respectively. It is believed that SPI-1 T3SS is responsible for invasion of non-phagocytic cells, while SPI-2 T3SS is essential for intracellular replication and systemic infection \[[@B4],[@B5]\].

In order to survive and replicate in an aerobic environment, organisms including *Salmonella*must cope with reactive oxygen species such as hydrogen peroxide (H~2~O~2~), which are formed in respiring cells as incomplete reduction products of molecular oxygen, and which can cause damage to DNA, RNA, protein, and lipids \[[@B6]-[@B8]\]. To respond to oxidative stress, bacteria activate a set of globally regulated genes, including two known stimulons: peroxide stimulons and superoxide stimulons \[[@B7],[@B9]-[@B12]\].

The response of *Salmonella*to oxidative stress represents a key component of its pathogenesis \[[@B7],[@B9]\]. Reactive oxygen species generated by the NADPH phagocytic oxidase system in phagocytes play an important role in controlling *Salmonella*replication in macrophages and systemic infection in the spleen \[[@B13],[@B14]\]. To combat the damaging effects of this oxidative stress and survive in macrophages during systemic infection such as in the spleen, it is believed that *Salmonella*uses unique strategies and expresses specific proteins to carry out defense and repair functions \[[@B7],[@B9]\]. While little is known about the expression of SPI-1 factors upon oxidative stress, several SPI-1 factors SipA, SopA, SopB, SopD, and SopE2 of *S. Typhimurium*were found to be expressed in the spleen of infected animals at the late stages of infection when *Salmonella*is believed to replicate in splenic macrophages \[[@B15],[@B16]\]. These results suggest that in addition to their generally recognized roles in invasion, the SPI-1 factors may also play an important role post-invasion, including a possible role in resistance to the oxidative stress generated by tissue macrophages. An understanding of the expression profiles of *Salmonella*SPI-1 factors and other proteins in the presence of reactive oxygen species such as H~2~O~2~should provide insight into the identification of virulent determinants important for *Salmonella*to survive in macrophages and cause systemic infection in the spleen *in vivo*.

The expression of *Salmonella*genes (including those encoding SPI-1 factors) *in vitro*under various conditions has been extensively studied \[[@B17]-[@B21]\]. However, most of these studies were performed by examining the transcription levels of *Salmonella*genes either using microarray or a reporter system \[[@B17],[@B19]-[@B23]\]. Recently, proteomic analysis of *Salmonella*protein expression in the spleen of infected animals has been reported \[[@B24]\]. Furthermore, Smith and co-workers have reported global protein profiles of *Salmonella enterica*serovars Typhimurium and Typhi cultured at the stationary phase, logarithmic (log) phase, or phagosome-mimicking culture conditions, and the expression profiles of proteins in infected macrophages \[[@B25]-[@B28]\]. However, to our knowledge, global expression profiling of *Salmonella*proteins upon exposure to reactive oxygen species such as H~2~O~2~has not been reported, and efforts to identify proteins whose expression levels are affected by oxidative stress have been limited mostly to a few proteins at a time \[[@B9],[@B29],[@B30]\]. In addition, expression of *Salmonella*proteins including those of SPI-1 *in vivo*during the established phase of infection has not been extensively studied.

In this study, we have modified the procedure of Stable Isotope Labeling by Amino acids in Cell culture (SILAC) \[[@B31],[@B32]\] to develop a mass spectrometry (MS)-based approach to carry out quantitative proteomic analysis of *Salmonella*. Using this procedure, we have identified 76 proteins from a strain of *Salmonella enterica*serovar Enteritidis that are differentially regulated upon exposure to H~2~O~2~. The results on selected SPI-1 proteins were confirmed by Western blot analyses, validating the accuracy and reproducibility of our approach for quantitative analyses of protein expression. The expression of several SPI-1 proteins was further analyzed in infected macrophages and in the spleen of infected mice. These results suggest a possible role for SPI-1 proteins in *Salmonella*infection in the presence of oxidative stress and in systemic infection in an animal host.

Results
=======

Stable isotope labeling of *Salmonella*with ^15^N-containing growth media
-------------------------------------------------------------------------

We used a virulent clinical isolate of *Salmonella enterica*serovar Enteritidis SE2472 for this analysis. Our previous studies have shown that almost all clinical strains analyzed, including SE2472, exhibited similar levels of resistance to H~2~O~2~\[[@B33]\]. We chose this strain to examine the expression profiles of *Salmonella*proteins upon exposure to H~2~O~2~, a stress condition relevant to what *Salmonella*may encounter in macrophages and in the spleen during bacterial infection *in vivo*. To determine protein levels in two or more different biological states (e.g. in the absence and presence of H~2~O~2~), we modified the SILAC procedure (Figure [1](#F1){ref-type="fig"}) in which the introduction of a stable isotope ^15^N into the protein mixture provides a means to quantitatively analyze two sets of protein mixtures simultaneously \[[@B31],[@B32]\]. Stable isotope-based quantification relies on the premise that the relative signal intensity of two analytes that are chemically identical but different in stable isotope compositions can be resolved in a mass spectrometer, thus giving a true measure of the relative abundance of the analytes \[[@B31],[@B32],[@B34],[@B35]\]. To determine the efficiency of the labeling and incorporation of the heavy isotope, SE2472 was grown in ^15^N-containing LB broth-like media. SE2472 appeared to grow in the normal (^14^N) and ^15^N-containing LB broth-like media as well as in the LB broth as they reach similar titers in these media (data not shown). Bacteria were harvested at different time points and the extent of ^15^N-labeling of *Salmonella*proteins was examined by MS analysis in comparison to the control ^14^N labeled bacteria. Growth in ^15^N-labeled media for 6 hours or more was sufficient to label the entire *Salmonella*proteome with ^15^N (data not shown). The proteins examined and all the peptides of each protein appeared to have identical incorporation rate. Accordingly, all labeling experiments were carried out for at least 6 hours in this study.

![**Schematic representation of metabolic labeling of *Salmonella*with the ^15^N isotope**.](1471-2180-10-166-1){#F1}

Wild type-like growth phenotypes of labeled bacteria
----------------------------------------------------

One of our main objectives in the study was to use the expression of the labeled proteins to monitor *Salmonella*protein levels when *Salmonella*is exposed to oxidative stress. Thus, it is necessary to determine whether ^15^N-labeled *Salmonella*retain the growth and oxidative stress-resistant properties of the unlabeled SE2472 *in vitro*. ^15^N-labeled *Salmonella*appeared to grow as well as the unlabeled bacteria in LB broth (Figure [2A](#F2){ref-type="fig"}). No detectable difference in the colony size and morphology was observed between these two cultures. Furthermore, no difference was detected between the survival of the N^14^- and N^15^-labeled bacteria in either the LB broth-like labeling media or the LB broth in the presence of 5 mM H~2~O~2~, a concentration well below the minimal inhibition concentration (MIC) of SE2472 (20 mM) but substantially above the natural extracellular environment (Figure [2B](#F2){ref-type="fig"}).

![**Growth analysis of *S. Enteritidis*SE2472**. (A) Growth of normal (^14^N) and ^15^N-labeled *S. Enteritidis*SE2472 in LB broth. (B) The survival of normal (^14^N) and ^15^N-labeled *Salmonella*grown in LB broth-like labeling media after exposure to H~2~O~2~, compared to the survival of the same cultures grown in LB broth after exposure to H~2~O~2~(inset).](1471-2180-10-166-2){#F2}

Quantitative proteomic analyses of *Salmonella*protein expression
-----------------------------------------------------------------

To investigate the expression profiles of *Salmonella*upon exposure to oxidative stress, single colonies of SE2472 were grown in ^14^N- or ^15^N-containing LB broth-like media and only the ^15^N culture was treated with 5 mM H~2~O~2~for 2 hours to simulate the oxidative stress condition (Figure [1](#F1){ref-type="fig"}). Total proteins from the ^14^N- and ^15^N- samples were extracted and quantified. A 1:1 (by weight) mixture of two samples was prepared and 200 μg of total proteins were separated by two-dimensional (2-D) gel electrophoresis. Visualization by silver staining revealed approximately 200 protein spots across the pI and molecular weight range of the gel, which were further investigated using quantitative proteomics (Figure [3](#F3){ref-type="fig"}).

![**Two-dimensional gel electrophoresis of *S. Enteritidis*SE2472 total proteins**. Approximately 200 μg of total SE2472 proteins were loaded onto a 2 D gel and visualized by the silver staining method.](1471-2180-10-166-3){#F3}

Analysis with matrix-assisted laser desorption/ionisation-time of flight (MALDI-ToF) mass spectrometry was performed to map tryptic fragments from the mixture of the ^14^N- and ^15^N-(unexposed and H~2~O~2~-exposed) samples, where two sets of peptide fingerprints appear on the same spectrum (Figure [4](#F4){ref-type="fig"}, Table [1](#T1){ref-type="table"}). We distinguished the two sets of peaks by initially using the ^14^N peaks to identify the protein and amino acid contents of each peak (Figure [4](#F4){ref-type="fig"} and Table [1](#T1){ref-type="table"}), then using peak information to deduce the location of the ^15^N peaks. The ratio of the peak heights (^15^N/^14^N) was then used for relative quantification (Figures [1](#F1){ref-type="fig"} and [4](#F4){ref-type="fig"}). Figure [4](#F4){ref-type="fig"} shows an example taken from a protein sample, a tryptic peptide fragment FTGWYDVDLSEK (MW 1459.81) from *S. Enteritidis*phosphoglyceromutase. A peak at m/z 1473 represents the ^15^N-labeled population (Figure [4](#F4){ref-type="fig"}, upper spectrum), which does not appear in the unlabeled population. The ratio of two peak intensities (27 and 17, respectively) represents a relative protein expression level of 0.6, or a 40% downregulation. To further increase the accuracy of our results, each set of experiments was repeated three times. Only those proteins that were detected and identified with high confidence in all three independent experiments are listed in Table [2](#T2){ref-type="table"}.

###### 

MALDI-ToF analysis and identification of SE2472 proteins.

  -------------------------------------------------------------------------------------------------------
  Locus\      Description\                                            Gene\   Mass\    pI\    Coverage\
  Tag                                                                         (KDa)           
  ----------- ------------------------------------------------------- ------- -------- ------ -----------
  PSLT011     Dlp (SrgA)                                              srgA    24.74    8.58   38%

  STM0007     Transaldolase B                                         talB    35.15    5.09   19%

  STM0012     Chaperone protein *dnaK*(Heat shock protein 70)         dnaK    69.2     4.84   22%

  STM0013     Chaperone protein *dnaJ*                                dnaJ    41.31    8.41   25%

  STM0093     Organic solvent tolerance protein                       Imp     89.8     5.21   23%

  STM0102     L-arabinose isomerase                                   araA    55.89    5.88   23%

  STM0158     Aconitate hydratase 2                                   acnB    82.2     5.35   29%

  STM0217     Elongation factor Ts                                    tsf     33.18    5.16   41%

  STM0316     Aminoacyl-histidine dipeptidase                         pepD    52.69    5.17   15%

  STM0432     Phosphonoacetaldehyde hydrolase                         phnX    28.57    5.58   41%

  STM0435     Nucleotide-binding protein                              yajQ    18.31    5.6    52%

  STM0447     Trigger factor                                          tig     48.02    4.84   23%

  STM0488     Adenylate kinase                                        adk     23.49    5.53   51%

  STM0536     Peptidyl-prolyl cis-trans isomerase B                   ppiB    18.13    5.52   45%

  STM0608     Chain T, crystal structure of Ahpc                      ahpC    20.64    5.03   24%

  STM0730     Citrate synthase                                        gltA    48.11    6.35   24%

  STM0772     Phosphoglyceromutase                                    gpmA    28.48    5.78   19%

  STM0776     UDP-galactose 4-epimerase                               galE    37.28    5.79   31%

  STM0781     Molybdate transporter periplasmic protein               modA    27.5     6.53   67%

  STM0794     Biotin synthase                                         bioB    38.8     5.42   53%

  STM0830     Glutamine-binding periplasmic protein precursor         glnH    27.23    8.74   67%

  STM0877     Putrescine-binding periplasmic protein precursor        potF    41       6.02   35%

  STM0999     Outer membrane protein F precursor                      ompF    40.05    4.73   28%

  STM1091     Secretory Effector Protein                              SopB    61.93    9.27   42%

  STM1220     N-acetyl-D-glucosamine kinase                           nagK    33.06    5.09   29%

  STM1231     DNA-binding response regulator in PhoQ system           phoP    25.61    5.28   33%

  STM1290     Glyceraldehyde-3-phosphate dehydrogenase                gapA    36.1     6.33   29%

  STM1296     Putative oxidoreductase                                 ydjA    20.13    6.75   29%

  STM1302     Exonuclease III                                         xthA    30.79    6.19   23%

  STM1303     Succinylornithine transaminase                          astC    43.72    6.13   34%

  STM1310     NAD synthetase                                          nadE    30.57    5.36   27%

  STM1378     Pyruvate kinase I                                       pykF    50.66    5.66   31%

  STM1431     Superoxide dismutase                                    sodB    21.35    5.58   35%

  STM1544     PhoPQ-regulated protein                                 pqaA    59.27    6.87   20%

  STM1567     Alcohol dehydrogenase                                   adhP    35.49    5.8    42%

  STM1589     Putative NADP-dependent oxidoreductase                  yncB    39.2     5.6    23%

  STM1641     ATP-dependent helicase                                  hrpA    148.71   8.22   15%

  STM1661     Putative universal stress protein                       ydaA    35.62    5.17   66%

  STM1682     Thiol peroxidase                                        tpx     18.19    4.93   54%

  STM1714     DNA topoisomerase I                                     topA    97.03    8.56   26%

  STM1727     Tryptophan synthase                                     trpA    28.65    5.28   20%

  STM1746.S   Chain A, structural basis of multispecificity in Oppa   oppA    58.77    5.85   29%

  STM1796     Trehalase, periplasmic                                  treA    63.6     5.19   63%

  STM1886     Glucose-6-phosphate 1-dehydrogenase                     zwf     55.92    5.52   26%

  STM1923     Chemotaxis protein *motA*                               motA    32.08    5.47   31%

  STM1954     Cystine-binding periplasmic protein precursor           fliY    28.79    8.81   23%

  STM1959     Flagellin                                               fliC    51.62    4.79   56%

  STM2104     Phosphomannomutase in colanic acid gene cluster         cpsG    50.02    5.18   20%

  STM2167     NADH independent D-lactate dehydrogenase                dld     65.05    6.47   31%

  STM2190     D-galactose binding periplasmic protein                 mglB    35.81    5.81   31%

  STM2203     Endonuclease IV                                         nfo     31.2     5.17   45%

  STM2205     Fructose-1-phosphate kinase                             fruK    33.71    5.36   39%

  STM2282     Glycerophosphodiester phosphodiesterase                 glpQ    40.42    5.66   24%

  STM2337     Acetate kinase                                          ackA    43.26    5.93   21%

  STM2347     Putative phosphoesterase                                yfcE    19.91    5.93   43%

  STM2362     Amidophosphoribosyltransferase                          purF    56.56    5.51   23%

  STM2501     Polyphosphate kinase                                    ppk     80.46    8.7    30%

  STM2549     Anaerobic sulfide reductase                             asrB    30.61    6.24   28%

  STM2647     Uracil-DNA glycosylase                                  ung     25.48    6.56   67%

  STM2829     DNA strand exchange and recombinant protein             recA    37.94    5.08   28%

  STM2864     Iron transporter protein, *fur*regulated                sitD    33.7     7.84   41%

  STM2882     Secretory Effector Protein                              sipA    73.94    6.41   35%

  STM2884     Translocation Machinery Component                       sipC    42.98    8.88   38%

  STM2924     RNA polymerase sigma factor *rpoS*                      rpoS    37.93    4.86   29%

  STM2952     Enolase                                                 eno     36.24    5.13   30%

  STM2976     L-fucose isomerase                                      fucI    64.77    5.6    31%

  STM2993     Exonuclease V, alpha chain                              recD    67.05    8.02   36%

  STM3068     Fructose-bisphosphate aldolase                          fba     39.3     5.68   25%

  STM3069     Phosphoglycerate kinase                                 pgk     41.28    5.09   38%

  STM3186     Outer membrane channel protein                          tolC    53.39    5.42   31%

  STM3219     2,4-dieonyl-CoA reductase                               fadH    73.13    6.55   35%

  STM3225     Serine/threonine transporter                            sstT    43.41    8.43   33%

  STM3294     Phosphoglucosamine mutase                               glmM    47.44    5.74   32%

  STM3342     Stringent starvation protein A                          sspA    32.05    5.22   19%

  STM3359     Malate dehydrogenase                                    mdh     32.63    6.01   22%

  STM3380     Acetyl CoA carboxylase                                  accC    49.26    6.52   28%

  STM3401     Shikimate dehydrogenase                                 aroE    29.29    5.73   51%

  STM3445     Elongation factor Tu                                    tuf     43.26    5.3    32%

  STM3446     Elongation factor G                                     fusA    77.72    5.17   23%

  STM3484     DNA adenine methylase                                   dam     32.03    8.93   26%

  STM3496     Putative hydrolase                                      yrfG    72.4     5.23   19%

  STM3500     Phosphoenolpyruvate carboxykinase                       pckA    59.9     5.67   28%

  STM3502     Osmolarity response regulator                           ompR    27.35    6.04   31%

  STM3557     Glycerol-3-phosphatase transporter binding protein      ugpB    48.49    6.97   15%

  STM3612     2-dehydro-3-deoxygluconokinase                          kdgK    34.35    5.01   17%

  STM3884     D-ribose periplasmic binding protein                    rbsB    30.9     8.54   38%

  STM3968     Uridine phosphorylase                                   udp     27.38    6.32   34%

  STM3997     Thiol:disulfide interchange protein                     dsbA    22.9     6.3    54%

  STM4029     Putative acetyltransferase                              yiiD    36.92    6.08   34%

  STM4166     NADH pyrophosphatase                                    nudC    29.62    5.89   48%

  STM4256     Single-strand DNA-binding protein                       ssb     19.06    5.46   34%

  STM4329     Co-chaperonin *groES*                                   groES   10.19    5.36   56%

  STM4330     Chaperonin *groEL*                                      groEL   57.16    4.85   38%

  STM4343     Fumarate reductase                                      frdA    65.49    5.95   19%

  STM4359     DNA mismatch repair protein *mutL*                      mutL    67.76    6.51   21%

  STM4414     Inorganic pyrophosphatase                               ppa     19.68    5.01   43%

  STM4513     Putative permease                                       yjiG    16.12    7.76   61%

  STM4567     Deoxyribose-phosphate aldolase                          deoC    27.68    5.87   47%

  STM4568     Thymidine phosphorylase                                 deoA    47       4.96   38%

  STM4569     Phosphopentomutase                                      deoB    44.24    5.15   52%

  STM4598     Two-component response regulator                        arcA    45.56    5.47   58%

  STY2300     CDP-6-deoxy-D-xylo-4-hexulose-3-dehydrase               rfbH    48.1     5.27   46%

  STY2300     CDP-4-keto-6-deoxy-D-glucose-3-dehydrase                ddhC    48.2     5.35   39%
  -------------------------------------------------------------------------------------------------------

###### 

Quantitative analysis of the expression of SE2472 proteins upon exposure to H~2~O~2~.

  Locus Tag   Description                                             Gene    \% Change
  ----------- ------------------------------------------------------- ------- -----------
  PSLT011     Dlp (SrgA)                                              srgA    12 ± 2%
  STM0007     Transaldolase B                                         talB    0%
  STM0012     Chaperone protein *dnaK*(Heat shock protein 70)         dnaK    56 ± 7%
  STM0013     Chaperone protein *dnaJ*                                dnaJ    38 ± 3%
  STM0093     Organic solvent tolerance protein                       Imp     210 ± 30%
  STM0102     L-arabinose isomerase                                   araA    26 ± 2%
  STM0158     Bifunctional aconitate hydratase                        acnB    25 ± 5%
  STM0217     Elongation factor Ts                                    tsf     21 ± 4%
  STM0316     Aminoacyl-histidine dipeptidase                         pepD    9 ± 1%
  STM0432     Phosphonoacetaldehyde hydrolase                         phnX    31 ± 3%
  STM0435     Nucleotide-binding protein                              yajQ    0%
  STM0447     Trigger factor                                          tig     11 ± 2%
  STM0488     Adenylate kinase                                        adk     0%
  STM0536     Peptidyl-prolyl cis-trans isomerase B                   ppiB    0%
  STM0608     Chain T, crystal structure of Ahpc                      ahpC    0%
  STM0730     Citrate synthase                                        gltA    42 ± 5%
  STM0772     Phosphoglyceromutase                                    gpmA    -40 ± 10%
  STM0776     UDP-galactose 4-epimerase                               galE    23 ± 2%
  STM0781     Molybdate transporter periplasmic protein               modA    11 ± 2%
  STM0794     Biotin synthase                                         bioB    0%
  STM0830     Glutamine-binding periplasmic protein precursor         glnH    10 ± 3%
  STM0877     Putrescine-binding periplasmic protein precursor        potF    11 ± 2%
  STM0999     Outer membrane protein F precursor                      ompF    0%
  STM1091     Secretory Effector Protein                              SopB    -55% ± 7%
  STM1220     N-acetyl-D-glucosamine kinase                           nagK    12 ± 3%
  STM1231     DNA-binding response regulator in PhoQ system           phoP    20 ± 6%
  STM1290     Glyceraldehyde-3-phosphate dehydrogenase                gapA    31 ± 3%
  STM1296     Putative oxidoreductase                                 ydjA    -30 ± 5%
  STM1302     Exonuclease III                                         xthA    0%
  STM1303     Succinylornithine transaminase                          astC    41 ± 7%
  STM1310     NAD synthetase                                          nadE    9 ± 1%
  STM1378     Pyruvate kinase I                                       pykF    87 ± 12%
  STM1431     Superoxide dismutase                                    sodB    110 ± 20%
  STM1544     PhoPQ-regulated protein                                 pqaA    19 ± 2%
  STM1567     Alcohol dehydrogenase                                   adhP    9 ± 2%
  STM1589     Putative NADP-dependent oxidoreductase                  yncB    12 ± 2%
  STM1641     ATP-dependent helicase                                  hrpA    20 ± 3%
  STM1661     Putative universal stress protein                       ydaA    140 ± 20%
  STM1682     Probable peroxidase                                     tpx     19 ± 2%
  STM1714     DNA topoisomerase I                                     topA    17 ± 4%
  STM1727     Tryptophan synthase                                     trpA    37 ± 9%
  STM1746.S   Chain A, structural basis of multispecificity in Oppa   oppA    0%
  STM1796     Trehalase, periplasmic                                  treA    25 ± 3%
  STM1886     Glucose-6-phosphate 1-dehydrogenase                     zwf     0%
  STM1923     Chemotaxis protein *motA*                               motA    14 ± 3%
  STM1954     Cystine-binding periplasmic protein precursor           fliY    9 ± 2%
  STM1959     Flagellin                                               fliC    0%
  STM2104     Phosphomannomutase in colanic acid gene cluster         cpsG    23 ± 6%
  STM2167     NADH independent D-lactate dehydrogenase                dld     16 ± 5%
  STM2190     D-galactose binding periplasmic protein                 mglB    34 ± 3%
  STM2203     Endonuclease IV                                         nfo     0%
  STM2205     Fructose-1-phosphate kinase                             fruK    35 ± 3%
  STM2282     Glycerophosphodiester phosphodiesterase                 glpQ    15 ± 3%
  STM2337     Acetate kinase                                          ackA    23 ± 3%
  STM2347     Putative phosphoesterase                                yfcE    0%
  STM2362     Amidophosphoribosyltransferase                          purF    10 ± 4%
  STM2501     Polyphosphate kinase                                    ppk     7 ± 3%
  STM2549     Anaerobic sulfide reductase                             asrB    0%
  STM2647     Uracil-DNA glycosylase                                  ung     27 ± 2%
  STM2829     DNA strand exchange and recombinant protein             recA    24 ± 2%
  STM2864     Iron transporter protein, fur regulated                 sitD    -45 ± 8%
  STM2882     Secretory Effector Protein                              sipA    0%
  STM2884     Translocation Machinery Component                       sipC    301 ± 30%
  STM2924     RNA polymerase sigma factor *rpoS*                      rpoS    13 ± 2%
  STM2952     Enolase                                                 eno     23 ± 4%
  STM2976     L-fucose isomerase                                      fucI    0%
  STM2993     Exonuclease V, alpha chain                              recD    0%
  STM3068     Fructose-bisphosphate aldolase                          fba     52 ± 7%
  STM3069     Phosphoglycerate kinase                                 pgk     20 ± 3%
  STM3186     Outer membrane channel protein                          tolC    0%
  STM3219     2,4-dieonyl-CoA reductase                               fadH    24 ± 3%
  STM3225     Serine/threonine transporter                            sstT    23 ± 3%
  STM3294     Phosphoglucosamine mutase                               glmM    18 ± 2%
  STM3342     Stringent starvation protein A                          sspA    -20 ± 4%
  STM3359     Malate dehydrogenase                                    mdh     36 ± 6%
  STM3380     Acetyl CoA carboxylase                                  accC    11 ± 2%
  STM3401     Shikimate dehydrogenase                                 aroE    12 ± 3%
  STM3445     Elongation factor Tu                                    tuf     0%
  STM3446     Elongation factor G                                     fusA    9 ± 2%
  STM3484     DNA adenine methylase                                   dam     26 ± 3%
  STM3496     Putative hydrolase                                      yrfG    0%
  STM3500     Phosphoenolpyruvate carboxykinase                       pckA    330 ± 40%
  STM3502     Osmolarity response regulator                           ompR    12 ± 3%
  STM3557     Glycerol-3-phosphatase transporter binding protein      ugpB    0%
  STM3612     2-dehydro-3-deoxygluconokinase                          kdgK    9 ± 2%
  STM3884     D-ribose periplasmic binding protein                    rbsB    31 ± 3%
  STM3968     Uridine phosphorylase                                   udp     11 ± 5%
  STM3997     Thiol:disulfide interchange protein                     dsbA    10 ± 5%
  STM4029     Putative acetyltransferase                              yiiD    0%
  STM4166     NADH pyrophosphatase                                    nudC    10 ± 2%
  STM4256     Single-strand DNA-binding protein                       ssb     19 ± 2%
  STM4329     Co-chaperonin *groES*                                   groES   51 ± 3%
  STM4330     Chaperonin *groEL*                                      groEL   43 ± 2%
  STM4343     Fumarate reductase                                      frdA    40 ± 2%
  STM4359     DNA mismatch repair protein mutL                        mutL    41 ± 3%
  STM4414     Inorganic pyrophosphatase                               ppa     0%
  STM4513     Putative permease                                       yjiG    -78 ± 15%
  STM4567     Deoxyribose-phosphate aldolase                          deoC    0%
  STM4568     Thymidine phosphorylase                                 deoA    -9 ± 2%
  STM4569     Phosphopentomutase                                      deoB    0%
  STM4598     Two-component response regulator                        arcA    10 ± 4%
  STY2300     CDP-6-deoxy-D-xylo-4-hexulose-3-dehydrase               rfbH    0%
  STY2300     CDP-4-keto-6-deoxy-D-glucose-3-dehydrase                ddhC    0%

Relative expression level in the presence of H~2~O~2~compared against control (in the absence of H~2~O~2~) is shown. An average of 10 peaks was used to calculate the mean intensity ratios and the error percentage of each protein spot. The results were the average from triplicate experiments. The limit of detection was arbitrarily set to 5% and any proteins that showed less than 5% change were classified as 0%.

![**Quantitation of proteins by their tryptic peptide fragments**. A tryptic peptide fragment FTGWYDVDLSEK (MW 1459.81) from *S. Enteritidis*phosphoglyceromutase was analyzed for the level of downregulation. A peak at m/z 1473 represents ^15^N-labeled population (upper spectrum), which does not appear in the unlabeled population. The ratio of two peak intensities (27 and 17, respectively) represents a relative protein expression level of 0.6, or a 40% downregulation.](1471-2180-10-166-4){#F4}

Automation of expression profiling
----------------------------------

Predicting the location of ^15^N peaks for any given peptide was a two-step process. First, the protein was identified and the amino acid contents of each peak were searched using the MASCOT software. Based on the number of nitrogen atoms in the peptide, a prediction was then made as to the molecular weight of the ^15^N peaks. To facilitate this process, we developed a custom VBScript for Microsoft Excel that automatically predicts ^15^N peak locations with a simple copy and paste feature. Using this script, many sets of peak data can be processed within minutes, virtually eliminating the need to manually inspect each peak for the number of nitrogen atoms.

Using the developed program, we generated a list of 103 SE2472 proteins and their expression profiles upon exposure to H~2~O~2~(Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). All these proteins were detected and identified with high confidence in all three independent experiments. We should note that the absence of a protein in our results does not necessarily mean it was not expressed and/or induced; instead its expression status is yet to be determined. The majority of protein expression was up-regulated, albeit at different levels. We further categorized proteins into different groups based on their functions, as shown in Table [3](#T3){ref-type="table"}. Interestingly, SipC and SopB, which are the SPI-1 translocase and effector, were differentially expressed in the presence of H~2~O~2~. SipC was about 3-fold higher and SopB was 2-fold lower in the exposed samples, while no significant change in the expression of another SPI-1 protein SipA was observed (Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

###### 

Expression proteomics of SE2472 upon exposure to H~2~O~2~, categorized by protein functions.

  Description                                 Change
  ------------------------------------------- -----------
  **Glycolysis/Gluconeogenesis**              
   Enolase                                    23 ± 4%
   Fructose-1-phosphate kinase                35 ± 3%
   Fructose-bisphosphate aldolase             52 ± 7%
   Phosphoenolpyruvate carboxykinase          330 ± 40%
   Phosphoglycerate kinase                    20 ± 3%
   Phosphoglyceromutase                       -40 ± 10%
   Phosphopyruvate hydratase                  12 ± 2%
   Pyruvate kinase I                          87 ± 12%
                                              
  **TCA Cycle**                               
   Aconitate hydratase 2                      18 ± 2%
   Bifunctional aconitate hydratase           25 ± 5%
   Citrate synthase                           42 ± 5%
   Malate dehydrogenase                       36 ± 6%
                                              
  **Transcription/Translation**               
   Elongation factor G                        9 ± 2%
   Elongation factor Ts                       21 ± 4%
   Elongation factor Tu                       0%
   Endonuclease IV                            0%
   RNA polymerase sigma factor *rpoS*         13 ± 2%
                                              
  **DNA Replication/Repair**                  
   ATP-dependent helicase                     20 ± 3%
   DNA adenine methylase                      26 ± 3%
   DNA mismatch repair protein mutL           41 ± 3%
   Single-strand DNA-binding protein          19 ± 2%
   Uracil-DNA glycosylase                     27 ± 2%
                                              
  **Type III Secretion System**               
   Secretory Effector Protein (SipA)          0%
   Translocation Machinery Component (SipC)   301 ± 30%
   Secretory Effector Protein (SopB)          -55% ± 7%
                                              
  **Pentose Phosphate Pathway**               
   Deoxyribose-phosphate aldolase             0%
   Glucose-6-phosphate 1-dehydrogenase        0%
   Phosphopentomutase                         0%
   2-dehydro-3-deoxygluconokinase             9 ± 2%
                                              
  **Nucleotide synthesis and metabolism**     
   Amidophosphoribosyltransferase             10 ± 4%
   Thymidine phosphorylase                    -9 ± 2%
   Uridine phosphorylase                      11 ± 5%
                                              
  **Amino acid synthesis and metabolism**     
   Shikimate dehydrogenase                    12 ± 3%
   Succinylornithine transaminase             41 ± 7%
   Tryptophan synthase                        37 ± 9%

Representative proteins are shown.

Validation of differential expression of the SPI-1 proteins
-----------------------------------------------------------

To demonstrate the validity of our proteomic results, we examined the relative abundance of SipA, SipC, and SopB by Western blot analysis. *Salmonella*strains SipA(HF), SipC(HF) and SopB(HF) were derived from SE2472 and contained a FLAG epitope tag sequence at the carboxyl terminus of *sipA*, *sipC*and *sopB*, respectively \[[@B36]\]. The tagged strains grew in LB broth as well as the parental strain SE2472, indicating that the insertion of the tag sequence did not significantly affect bacterial growth *in vitro*\[[@B36]\](data not shown). To study the pathogenesis of the tagged strains in oral and systemic infection, we infected BALB/c mice intragastrically and intraperitoneally with the tagged *Salmonella*strains and compared infected mice to those infected with the wild type SE2472. The survival of infected mice and the colonization of spleen, liver, and ileum of the infected mice by *Salmonella*were determined at different time points post infection. For BALB/c mice infected intragastrically with 1 × 10^6^CFU of the tagged or the wild type strains, all infected mice died within 7 days post infection and no significant difference was observed among the wild type and the tagged strains (Figure [5A](#F5){ref-type="fig"}). No significant difference in the colonization of the internal organs such as spleen, liver, and ileum, was observed between the parental (wild type) SE2472 strain and the tagged strains regardless of the route of inoculation (Table [4](#T4){ref-type="table"}). These results suggest that tagging of the target ORF does not impair the invasiveness, growth, and virulence of the bacteria, and that the tagged strains can be used as model strains to study infection of *Salmonellain vitro*and *in vivo*, including the expression of the SPI-1 proteins.

###### 

The numbers of bacteria (CFU) in different organs from animals.

  *Salmonella*strains   Colonization (i.p.)   Colonization (i.g.)               
  --------------------- --------------------- --------------------- ----------- -----------
  SE2472                9.0 ± 0.5             8.3 ± 0.5             9.1 ± 0.5   8.2 ± 0.5
                                                                                
  SipA(HF)              9.1 ± 0.5             8.2 ± 0.5             8.9 ± 0.5   8.3 ± 0.5
                                                                                
  SipC(HF)              9.2 ± 0.5             8.4 ± 0.5             9.0 ± 0.5   8.2 ± 0.5
                                                                                
  SopB(HF)              9.0 ± 0.5             8.4 ± 0.5             9.2 ± 0.5   8.1 ± 0.5

\* BALB/c mice were either infected intraperitoneally (i.p.) with 1 × 10^4^CFU or intragastrically (i.g.) with 1 × 10^6^CFU bacteria. A group of 5 mice was infected and the organs were harvested at 4 (for i.p. infection) or 6 days (for i.g. inoculation) post infection. Each sample was analyzed in triplicate and the analysis was repeated at least three times. The CFU of the sample was expressed as the average of the values obtained. The concentrations of bacteria were recorded as CFU/ml of organ homogenate. The limit of bacteria detection in the organ homogenates was 10 CFU/ml.

![**(A) Mortality of BALB/c mice infected with *Salmonella*strains, (B) Western blot analyses of the synthesis of the tagged proteins from SE2472 (lane 1), SipC(HF) (lanes 2-3), SipA(HF) (lanes 4-5), and SopB(HF) (lanes 6-7), and (C) Effect of the treatment of hydrogen peroxide on the expression of the tagged SPI-1 proteins**. (A) Mice (5 animals per group) were infected intragastrically with 1 × 10^6^CFU of each bacterial strain. Mortality of mice was monitored for at least 10 days postinfection. (B) The expression of bacterial FliC was used as the internal control. The bacterial strains were grown in LB broth in the absence (-, lanes 2, 4, and 6) and presence of 5 mM H~2~O~2~(H~2~O~2~, lanes 3, 5, and 7) at 37°C for 2 hours. SE2472 was grown in the absence of H~2~O~2~(lane 1). Protein samples were separated in SDS-polyacrylamide gels and reacted with antibodies against the FLAG sequence (top panel) and FliC (low panel). Each lane was loaded with material from 5 × 10^7^CFU bacteria. The molecular masses of some of the proteins in the PageRuler protein size markers (Fermentas) are shown and given in kiloDaltons (KD). (C) Cultures of the tagged strains SipA(HF), SipC(HF), and SopB(HF) were grown in the absence and presence of 5 mM H~2~O~2~, as described in Methods and Materials. The values, which are the means from triplicate experiments, represent the relative percentage of the level of the tagged proteins from the bacteria grown in the presence of 5 mM H~2~O~2~to those in the absence of H~2~O~2~.](1471-2180-10-166-5){#F5}

To determine the effect of H~2~O~2~on the expression of the tagged ORFs, bacterial strains were grown in LB broth in the absence and presence of H~2~O~2~. Western blot analyses were used to determine the expression of the tagged proteins with an anti-FLAG antibody (Figure [5B](#F5){ref-type="fig"}, top panel). The expression of bacterial FliC protein, which was not significantly altered in the presence of 5 mM H~2~O~2~(Table [2](#T2){ref-type="table"}), was used as the internal control (Figure [5B](#F5){ref-type="fig"}, lower panel). Normalization of samples was also carried out by loading total proteins extracted from the same CFU (e.g. 5 × 10^7^CFU) of bacteria in each lane. Consistent with the results from our proteomic analyses (Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}), the levels of SipC and SopB were about 3-fold higher and 2-fold lower in the presence of H~2~O~2~, respectively, while no change in the expression of SipA was detected (Figure [5B-C](#F5){ref-type="fig"}).

Differential expression of SPI-1 factors in cultured macrophages and the spleen of infected animals
---------------------------------------------------------------------------------------------------

Immunodetection of the SPI-1 proteins in cultured media in the absence and presence of H~2~O~2~validated the proteomic observations. To evaluate the presence of these proteins in an environment more relevant to infection, the tagged *Salmonella*strains were used to infect macrophages and mice, and the expression of the tagged proteins was determined by immunodetection at different time points following infection. The expression of the tagged proteins in the bacterial strains isolated from the macrophages and the spleen of infected mice was detected using Western blot analysis with an anti-FLAG antibody and normalized using the expression of bacterial protein DnaK as the internal control (Figure [6A-B](#F6){ref-type="fig"}). Normalization of protein samples was also carried out by loading total proteins extracted from the same CFU (e.g. 5 × 10^7^CFU) of bacteria in each lane. The protein level of DnaK did not appear to be significantly different in bacteria recovered from macrophages \[[@B26]\], and from the spleen of infected animals as similar amount of the DnaK protein was detected from 5 × 10^7^CFU of each bacterial strain regardless of infection route (intraperitoneally or intragastrically) or time point postinfection (12-24 hours or 5-7 days)\[[@B16]\](data not shown).

![**Western blot analyses of the expression of the tagged proteins from bacterial strains SE2472 (lanes 1 and 11), SipC(HF) (lanes 2-4, 12-13), SipA(HF) (lanes 5-7, 14-15), and SopB(HF)(lanes 8-10, 16-17)**. In (A), bacterial protein samples were isolated from macrophages at 0.2, 1, and 5 hours of postinfection. In (B), BALB/c mice were intraperitoneally infected with 1 × 10^6^and 1 × 10^4^CFU of the tagged strains, and internalized bacteria were recovered from the spleen at 0.5 days and 4 days post inoculation, respectively. The expression of bacterial DnaK was used as the internal control. Protein samples were reacted with antibodies against the FLAG sequence (top panel) and DnaK (low panel). Each lane was loaded with material from 5 × 10^7^CFU bacteria. (C-D). Level of tagged proteins from the bacterial strains recovered from the macrophages and spleens of infected mice as determined in (A) and (B). The values, which are the means of triplicate experiments, represent the relative percentage of the levels of the tagged proteins in the bacteria recovered from macrophages (C) at 5 hours postinfection and from the spleen at 5 days postinoculation (D), as compared to those in the bacteria recovered from macrophages at 0.2 hours postinfection and from spleen at 0.5 days post inoculation, respectively.](1471-2180-10-166-6){#F6}

In cultured macrophages, SipA, SipC, and SopB were all expressed at the early phase (e.g. 0.2 h) of infections. However, by 5 hr post infection, the levels of the three SPI-1 proteins diverged, with the SipC level increased, the SopB level decreased while SipA level remained unchanged (Figure [6A](#F6){ref-type="fig"} and [6C](#F6){ref-type="fig"}). To determine the relative abundance of these proteins in the spleen during systemic infection, BALB/c mice were infected intraperitoneally. *Salmonella*was recovered from the spleen at different time points postinfection, and the expression levels of the tagged proteins were determined. Similar to the results of macrophage infection, all three proteins were detected during the early stage of infection (i.e. 0.5 days). However, at a later stage of systemic infection (i.e. 5 days), the level of SipC increased and the level of SopB decreased while the level of SipA remained unchanged (Figure [6B](#F6){ref-type="fig"} and [6D](#F6){ref-type="fig"}). These results correlated with those observed in the proteomic analyses and in the macrophage experiments. Furthermore, these data strongly suggest that different SPI-1 factors are specifically expressed at late stage of *Salmonella*infection, and highlight a possible role of SipC in late phase of macrophage and *in vivo*infections of *Salmonella*.

Discussion
==========

Stable isotope labeling procedure coupled with MS-based analysis for quantitative proteomic study of bacterial protein expression
---------------------------------------------------------------------------------------------------------------------------------

In the postgenomic era, new methodologies are needed that can quantitatively, globally, and accurately measure protein expression in cells and tissues \[[@B37]\]. In this study, we have modified the SILAC method to develop a stable isotope labeling procedure coupled with MS analysis to carry out quantitative proteomic analysis of *Salmonella*. As a \"proof of principle\" pilot study, a total of 103 SE2472 proteins were monitored for their expression profiles upon exposure to H~2~O~2~.

At least seventy six proteins have been found to be modulated in the presence of H~2~O~2~. For example, the expression of SPI-1 proteins SipC and SopB was found to be differentially regulated in the presence of H~2~O~2~, while the expression of SipA remained unchanged. The level of SipC increased with H~2~O~2~exposure, and the level of SopB decreased. These results were confirmed using Western blot analyses of protein expressions from FLAG-tagged *Salmonella*strains incubated with H~2~O~2~, validating the accuracy and reproducibility of our system for quantitative analyses of protein expression.

Modulation of *Salmonella*protein expressions upon exposure to oxidative stress
-------------------------------------------------------------------------------

Many *Salmonella*proteins we analyzed showed a moderate amount of up-regulation upon exposure to oxidative stress (Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}), consistent with earlier studies involving *E. coli*\'s response to oxidative stress \[[@B9]-[@B11],[@B38]\]. For example, RecA (DNA strand exchange and recombinant protein) has been shown to be induced along with members of heat shock proteins \[[@B39]\]. The expression of superoxide dismutase SodB, which is a part of the SoxRS system \[[@B6],[@B7],[@B9]\], increased by 110%. When categorized by protein functions, we observed several patterns (Table [3](#T3){ref-type="table"}). First, many enzymes involved in glycolysis and the TCA cycle were upregulated, showing up to a 330% increase. Consistent with the increase in general metabolism, amino acid biosynthesis was also affected in a positive fashion. Considering that intermediates from the glycolytic pathway are used in amino acid biosynthesis, the overall upregulation in downstream pathways is expected. This is consistent with our previous observations that amino acid supplementation increased the resistance of *E. coli*to H~2~O~2~\[[@B38]\]. Interestingly, the pentose phosphate pathway was relatively unaffected in the presence of H~2~O~2~. Since one of the primary functions of the pathway is to generate ribose-5-phosphate for the synthesis of nucleotides and nucleic acids, other enzymes involved in nucleotide biosynthesis should show little change either. As expected, three such enzymes detected in this study (i.e. amidophosphoribosyltransferase, thymidine phosphorylase, and uridine phosphorylase) showed a varied response, ranging from a minor upregulation to a downregulation (Table [3](#T3){ref-type="table"}). Further investigation of additional enzymes involved in the process should reveal the nature of this response.

We have noted that different proteins within the same operon may exhibit different expression levels in our results. Differential expression of proteins within the same operon has been reported \[[@B40]\] and may represent a regulatory mechanism for the expression of functional protein complexes. We have also noted that in some instances one protein was detected while another within the same operon was not. For example, redundant hydrogen peroxide scavenger systems have been reported to be present in *Salmonella*\[[@B41]\]. In our results, AhpC was not regulated while the other scavengers (KatE, KatG, KatN and TsaA) were not detected. One of the reasons for the divergence from expected protein level could be the limitation of the methodology we used in the study.

We used two-dimensional (2-D) gel electrohphoresis coupled with peptide fingerprinting by mass spectrometry which allowed us to perform global protein profiling quantitatively. However, our methodology is limited to proteins that can be detected by 2-D gel electrophoresis and identified by peptide fingerprinting. Proteins with low abundance or could not be identified by peptide fingerprinting for various reasons (e. g. post-translational modifications, resistance to trypsin digestion, or poor ionization of peptides) were not included in our analysis. Thus, our study by no means encompasses all the possible proteins expressed by SE2472 and we are presenting only the proteins we were able to successfully identify by peptide fingerprinting with high confidence in all three independent experiments. The absence of a protein in our results does not necessarily mean it was not expressed and/or induced; instead its expression status is yet to be determined. Our results are consistent with the notion that current proteomic approaches, including liquid chromatography mass spectrometry (LC-MS) and MALDI-ToF procedures, do not have the capacity to detect the entire proteomes of *Salmonella*\[[@B25]-[@B28]\]. Each approach has been shown to detect a distinct set of *Salmonella*proteins that exhibited limited overlap of protein coverage, and these complementary approaches should be carried out independently to generate a complete and full coverage of bacterial proteomes.

Expression of SPI-1 proteins in post-invasion and late phase of *Salmonella*infection
-------------------------------------------------------------------------------------

Our proteomic results on SPI-1 proteins SipA, SipC, and SopB suggest that the expression of these proteins may be differentially modulated during infection under biologically relevant environments that resemble the oxidative stress condition. Efficient expression of SipA at late stage of infection in macrophages and in the spleen, as shown in our results, has been observed in *Salmonella enterica*serovar Typhimurium \[[@B15],[@B16]\]. This is consistent with its functions in modulating actin dynamics and bacterial localization in infected macrophages \[[@B42]-[@B44]\] and in inducing inflammatory response for supporting *Salmonella*infection \[[@B45],[@B46]\].

Our results of SopB protein expression are consistent with recent proteomic analysis results that *Salmonella enterica*serovar Typhimurium (strain 14028) reduced SopB protein expression by more than 2-fold within 4 hours of infection of RAW264.7-like macrophages \[[@B47]\]. SopB encodes a phosphoinositide phosphatase and is a multifunctional protein important for bacterial infection \[[@B48]\]. It facilitates bacterial invasion by inducing membrane ruffling and modulating actin polymerization \[[@B49]-[@B51]\], and stimulates inducible nitric oxide synthase (iNOS) production long after invasion and participates in the formation of the *Salmonella*-containing vacuole in macrophages \[[@B52]-[@B54]\]. Recently, SopB has been shown to carry out its diverse functions by localizing to different cellular compartments in a ubiquitin-dependent manner \[[@B48]\]. The reduced expression of SopB in the presence of H~2~O~2~and at later time points of infection in macrophages and in the spleen in our study is consistent with the notion that SopB negatively regulates expression of sorting nexin 6 (SNX6), a protein involved in intracellular transport \[[@B47]\].

Our results also provide the first direct evidence that SipC is expressed in the spleen at late stages of *Salmonella enterica*serovar Enteritidis infection in mice. SipC is a *Salmonella*invasion protein (Sip) that is central for the initiation of the bacterial entry process. SipC and SipB form an extracellular complex following their secretion through the SPI-1 T3SS, and they are thought to assemble into a plasma membrane-integral structure (translocon) that mediates effector delivery \[[@B55]-[@B57]\]. Furthermore, SipC has been reported to promote actin nucleation and contribute to *Salmonella*-induced inflammation \[[@B58]\]. While the expression of SipC has been studied *in vitro*, its expression in the spleen has not been extensively investigated. The induced expression of SipC in *Salmonella*in the presence of oxidative stress and at late stages of infection in macrophages and in the spleen suggests that the level of this protein is highly regulated *in vivo*and that appropriate level of expression may contribute to the pathogenesis of *Salmonella*. This is consistent with recent observations that the translocase activity of SipC is important for the delivery of effector proteins and attachment of *Salmonella*to non-phagocytic cells; however, in the context of systemic infection, its actin-binding activity may facilitate bacterial infection of phagocytes \[[@B5],[@B58],[@B59]\]. Thus, examination of the expression of SipC and other SPI-1 factors both *in vitro*and *in vivo*in the context of infection, as reported in our study, is crucial to ultimately understand the actual functions and actions of these factors.

Using a different quantitative proteomic analysis approach without stable isotope labeling, Smith and co-workers have recently reported the protein expression of *Salmonella enterica*serovars Typhimurium and Typhi that grew in different culture conditions (e.g. stationary, log, and phagosome-mimicking conditions) and in macrophages \[[@B25]-[@B28]\]. Proteomic analysis of *Salmonella*protein expression in the spleen of infected animals has also been reported \[[@B24]\]. In these studies, the protein expression of the *S. Typhimurium*homologs of many of the oxidative stress-responsive proteins identified in our study were found to be modulated under phagosome-mimicking conditions and in macrophages, further validating our analysis as an accurate and reproducible approach for quantitative proteomic analysis. Some of our protein expression results may not be consistent with those of messenger RNA expression that have been recently published \[[@B19]-[@B23]\] as the expression of many *Salmonella*genes is tightly controlled both transcriptionally and post-transcriptionally \[[@B18],[@B60]\]. Our results of protein expression *in vivo*may not necessarily correlate with the previous observations *in vitro*because of the different environments *Salmonella*was exposed to. The difference between our results and previously published reports may also be due to the difference in the serovars and strains used for the studies, and the coverage of the proteins due to different methodologies used for the studies \[[@B25]-[@B28],[@B33]\]. None of these previous studies has reported the differential expression of SipA, SipC, and SopB in hydrogen peroxide-treated *Salmonella*, as described in our study. Our results complemented and further extended previous proteomic analysis of *Salmonella*, and furthermore, demonstrated the importance of examining the expression of *Salmonella*proteins, including SPI-1 proteins, *in vitro*using different quantitative proteomic analyses and *in vivo*in the context of infection.

Each of the currently-available proteomic approaches, including LC-MS and MALDI-ToF procedures, can only detect a subset of *Salmonella*proteins and may exhibit limited overlap of protein coverage with other methods \[[@B25]-[@B28]\]. It is suggested that these complementary approaches should be carried out independently to generate a comprehensive coverage of bacterial proteomes. Further investigation with our quantitative proteomic approach, in combination with examination and confirmation of the expression of these proteins *in vivo*, should provide significant insights into the role of these proteins in pathogenesis during *Salmonella*infection.

Conclusion
==========

We have employed stable isotope labeling coupled with mass spectrometry to carry out a quantitative proteomic analysis of *Salmonellaenterica*serovar Enteritidis. Seventy-six proteins whose expression is differentially modulated upon exposure to H~2~O~2~have been identified. SPI-1 effector SipC was expressed approximately 3-fold higher and SopB was expressed approximately 2-fold lower in the presence of H~2~O~2~, while no significant change in the expression of another SPI-1 protein SipA was observed. The expression of these SPI-1 factors was confirmed by Western blot analyses, validating the accuracy and reproducibility of our approach for quantitative analyses of protein expression. Furthermore, substantial expression of SipA and SipC but not SopB was found in the late phase of infection in macrophages and in the spleen of infected mice. This study provides the first direct evidence that SipC is highly expressed in the spleen at late stage of salmonellosis *in vivo*. Our results also suggest a possible role of the identified proteins, including SipC, in supporting the survival and replication of *Salmonella*under oxidative stress and during its systemic infection *in vivo*.

Methods
=======

Reagents and preparation of protein samples for proteomic analysis
------------------------------------------------------------------

All reagents were obtained from Sigma-Aldrich unless otherwise specified. *Salmonella enterica*serovar Enteritidis (clinical isolate SE2472) \[[@B33]\] was cultured in LB broth-like normal (^14^N) and ^15^N-labeled media (Silantes GmbH, München, Germany), which are identical in chemical composition. The percentage of ^15^N in the labeled media is more than 98% (Silantes GmbH, München, Germany). The cultures were inoculated with a starter culture grown in normal (^14^N) or ^15^N-labeled media until mid-log phase. Two hundred fifty milliliter culture medium was inoculated with each starter culture and grown at 37°C with shaking at 225 rpm for 4 h. ^15^N-labeled culture was treated with 5 mM H~2~O~2~, which is well below the minimal inhibition concentration (MIC) of SE2472 (20 mM), and both cultures were grown for 2 h following the addition of H~2~O~2~. Protein extraction was performed with B-PER^®^bacterial protein extraction reagent (Thermo Fisher Scientific, Rockford, IL) and quantified with D~c~Protein Assay Kit (Bio-Rad, Hercules, CA), which has an error rate of 2.5% in our experiments. We took this error rate into consideration by classifying any protein that had a 5% change or less as unchanged (having a 0% change).

Two-dimensional gel electrophoresis and visualization of bacterial proteins
---------------------------------------------------------------------------

Protein samples were further solubilized in rehydration buffer (8 M urea, 2% CHAPS, 50 mM DTT, 0.2% Bio-Lyte^®^3/10 ampholytes \[Bio-Rad, Hercules, CA\] and trace amount of Bromophenol Blue). ReadyStrip™ IPG strips (Bio-Rad, Hercules, CA) were loaded with 200 μg of protein samples (either normal or 1:1 mixture of normal and ^15^N-labeled samples) for preparative 2 D gels, and allowed to rehydrate for 18-22 h. Isoelectric focusing (IEF) was performed at 20°C using PROTEAN^®^IEF cell (Bio-Rad, Hercules, CA). A 3-step protocol (250 V-20 min/8,000 V-2.5 h/8,000 V-10,000 V.h) was used for the IEF procedure following manufacturer\'s recommendations (Bio-Rad, Hercules, CA).

After the IEF procedure, the IPG strips were reduced in Equilibration Buffer I (6 M urea, 2% SDS, 0.375 M Tris-HCl \[pH 8.8\], 20% glycerol, 2% DTT) and alkylated in Equilibration Buffer II (6 M urea, 2% SDS, 0.375 M Tris-HCl \[pH 8.8\], 20% glycerol, 0.25% iodoacetamide). Strips were loaded onto 8-16% Criterion™ Tris-HCl SDS gel (Bio-Rad, Hercules, CA) and electrophoresed at 200 V for 65 min. Gels were visualized using Coomassie Brilliant Blue R-250 or silver staining (Invitrogen, Carlsbad, CA).

Mass spectrometric identification of proteins
---------------------------------------------

Gels were scanned and protein spots of interest were excised using the Xcise automated gel processor (Proteome Systems, North Ryde, Australia). Gel spots were destained and washed, followed by in-gel tryptic digestion using proteomic grade trypsin (Sigma-Aldrich, St. Louis, MO). Peptide fragments were collected and purified using ZipTip™ C~18~reverse-phase prepacked resin (Millipore, Billerica, MA) and mixed with an equal volume of 10 mg/ml α-cyano-4-hydroxy-*trans*-cinnamic acid (Sigma-Aldrich, St. Louis, MO) in 0.1% trifluoroacetic acid (TFA)/50% acetonitrile solution and directly spotted onto a stainless steel target plate for mass analysis. Axima-CFR™ Plus (Shimadzu Biotech, Columbia, MD) was used for MALDI-ToF MS analysis, and 50-100 profiles were obtained for each sample, ensuring sufficient peak data for database interrogation. Probability-based scoring method with MASCOT database search engine (Matrix Science, Boston, MA) was used to identify each protein, based on the likelihood of search results being a random match. We used the following parameters for our protein identification: Database: NCBINR, MASCOT value cut off: greater than 62 (*p*\< 0.05), Taxonomy: *Salmonella*, Missed cleavage: 1, Peptide Tolerance: +/- 0.75 Da, Variable modification: none, Fixed modification: none, Enzyme: Trypsin, Mass Values: Monoisotopic.

Quantitative analysis
---------------------

Tryptic peak data from MASCOT database searches was tabulated and elemental composition of each peptide fragment was determined using an in-house data analysis software. The process was further automated using a custom VBScript written for Microsoft Excel, which was designed to calculate predicted ^15^N peak location based on the primary amino acid sequence of tryptic peptide fragments. ^14^N/^15^N mixture MS spectrum was used to obtain peak intensity ratio between labeled (^15^N) and unlabeled (^14^N) samples to give relative quantification data. An average of 10 peaks was used to calculate the mean intensity ratios and the error percentage of each protein spot. Significant outliers were manually removed from the data set to prevent them from affecting the results (less than 2%). To further increase the accuracy of our results, experiments were preformed three times, and the results were the average from the triplicate experiments. Only those proteins that were detected and identified with high confidence in all three independent experiments are listed in Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}.

Growth and survival analysis of *Salmonella*
--------------------------------------------

Strains SipA(HF), SipC(HF) and SopB(HF) are derivatives of the wild type *Salmonella enterica*serovar Enteritidis strain SE2472 with a FLAG tag inserted in-frame at the C-terminus of each corresponding protein and have been described previously \[[@B36]\]. Growth analysis of bacteria in LB or LB-like broth was carried out by first inoculating a single colony in 2 ml of either normal (^14^N) or ^15^N-labeled media and culturing at 37°C with shaking at 225 RPM overnight (about 16 hours) \[[@B16]\]. Thirty microliters of the overnight culture were then inoculated into 3 ml fresh normal or ^15^N-labeled media or LB broth and cultured at 37°C with shaking at 225 RPM. At 0, 2, 4, and 6 hours after inoculation, 100 μl of bacterial culture were collected to determine their colony forming unit (CFU)/ml by plating. *Salmonella*grew in normal (^14^N) or ^15^N-labeled media as well as in LB broth (data not shown). To study the survival of *Salmonella*after exposure to H~2~O~2~, 20 μl of the overnight culture grown in normal (^14^N) or ^15^N-labeled media, or LB broth were added to 2 ml of fresh normal (^14^N) or ^15^N-labeled media, or LB broth containing 5 mM H~2~O~2~. At different time points of incubation, 100 μl of bacterial culture were collected, diluted, and plated onto LB agar plates to determine their CFU/ml \[[@B16],[@B36]\]. Each sample was analyzed in triplicates and the analysis was repeated at least three times.

*In vitro*studies of the expression of the tagged SPI-1 proteins
----------------------------------------------------------------

Colonies of tagged strains were inoculated in 1 ml of LB broth and cultured at 37°C with shaking at 225 RPM for 16 hours. To study the effect of H~2~O~2~on the protein expression *in vitro*, 20 μl of overnight bacterial cultures were inoculated into 1 ml of antibiotic-free LB and shaken at 225 RPM at 37°C for 4 hours. The bacterial cultures were centrifuged at 5,000 × g for 5 minutes. The pelleted bacteria were re-suspended in 1 ml of fresh LB broth (control) or 1 ml of LB broth with 5 mM H~2~O~2~and shaken at 225 RPM at 37°C for an additional 2 hours, and then collected.

To prepare protein samples from *Salmonella*, bacterial cultures (1 ml) were centrifuged at 5,000 × g and 4°C for 10 minutes. The pellets were re-suspended in 200 μl of bacterial lysis buffer (8 M urea, 2% CHAPS, and 10 mM Tris, pH8.0), sonicated for 15 seconds three times with an interval of 30 seconds, centrifuged at 5,000 × g and 4°C for 10 minutes, and then transferred into fresh tubes for Western blot analysis.

Infection of cultured macrophages
---------------------------------

RAW264.7 macrophage-like cells (ATCC, Manassas, VA) were infected with stationary phase bacteria at a multiplicity of infection of 50. After incubation for 30 mins, infected cells were washed twice with phosphate-buffered saline (PBS) and incubated in DMEM medium supplemented with gentamicin (100 μg/ml) for 1 hour to eliminate extracellular bacteria. Then the cells were again washed twice with PBS, and incubated in DMEM supplemented with gentamicin (20 μg/ml). At various times postinfection, the cells were collected and resuspended in lysis buffer (120 mM NaCl, 4 mM MgCl~2~, 20 mM Tris-HCl \[pH 7.5\], 1%, Triton X-100) supplemented with protease inhibitors (complete EDTA-free cocktail, Roche Applied Science, Indianapolis, IN), incubated at 4°C for 1 hour, and centrifuged at 18,000 × g and 4°C for 10 minutes. The pellets that contained bacterial proteins were resuspended in PBS for Western blot analyses.

*In vivo*studies
----------------

BALB/c mice (6-8 weeks old) were obtained from Jackson Laboratory (Bar Harbor, ME). Overnight bacterial cultures were serially diluted to suitable CFU/ml in PBS before infection. To assess the virulence of the tested strains, groups of five mice were either inoculated intragastrically with 1 × 10^6^CFU per mouse or intraperitoneally with 1 × 10^2^CFU per mouse. Mice were monitored during the course of infection, and those animals that exhibited extreme stress or became moribund were euthanized. For organ colonization experiments, groups of five mice were inoculated intraperitoneally with 1 × 10^4^or 1 × 10^6^CFU per BALB/c mouse of the bacterial strains, and were euthanized at 4 days or 12 hours after inoculation, respectively. Mice were also intragastrically infected with 1 × 10^6^CFU per BALB/c mouse of the bacterial strains, and were euthanized at 6 days after inoculation. Organs were collected and homogenized in PBS at 4°C. An aliquot of each homogenate was used to determine its CFU/ml by serial dilution with PBS and plating onto LB agar plates. Each sample was analyzed in triplicate and the analysis was repeated at least three times. The CFU of the sample was expressed as the average of the values obtained. The concentrations of bacteria were recorded as CFU/ml of organ homogenate. The limit of bacteria detection in the organ homogenates was 10 CFU/ml. To prepare protein extracts for Western blot analyses, the homogenates of the spleen samples were centrifuged and the pellets that contained the bacteria were resuspended in PBS, following the procedures described previously \[[@B16]\]. All the experimental procedures with animals were in compliance with the guidelines and policies of the Animal Care and Use Committee (ACUC) of the University of California at Berkeley, and have been approved by the ACUC.

Western blot analyses
---------------------

The denatured polypeptides from bacterial lysates were separated on SDS-containing 10-12% polyacrylamide gels cross-linked with *N*, *N*\'\'-methylenebisacrylamide (0.05%), transferred electrically to nitrocellulose membranes (Bio-Rad, Hercules, CA), and reacted in an enzyme-linked immunoassay with a monoclonal anti-FLAG antibody (Sigma, St Louis, MO) and antibodies against *Salmonell*a FliC (BioLegend, San Diego, CA) and DnaK (StressGen, Victoria, British Columbia, Canada), followed by an anti-mouse IgG conjugated with alkaline phosphatase \[[@B16],[@B36]\]. The membranes were subsequently stained with a chemiluminescent substrate with the aid of a Western chemiluminescent substrate kit (Amersham Inc, GE Healthcare) and quantified with a STORM840 phosphorimager. Normalization of samples was also carried out by loading total proteins extracted from the same CFU (e.g. 5 × 10^7^CFU) of bacteria in each lane.

Authors\' contributions
=======================

KK, EY, GV, HG, JS, FL, and SL conceived the study, performed the research, analyzed the results, and wrote the paper. All authors read and approved the final manuscript.

Acknowledgements
================

We thank Cindy Loui, Yong Bai, Hongwei Gu, and Huiyuan Jiang for suggestions and excellent technical assistance. K. K., G. V., and E. Y. were partially supported by a Block Grant Predoctoral Fellowship (UC-Berkeley). The research has been supported by grants from USDA (CALR-2005-01892) and NIH (RO1-AI041927 and RO1-AI014842).
